FDA Shortages September/October 2021

You are subscribed to Drug Shortages for U.S. Food and Drug Administration. This information has recently been updated, and is now available.

• FDA Drug Shortages

  • Atropine Sulfate Ophthalmic Ointment (Updated - Resolved)

  • Bupivacaine Hydrochloride Injection (Updated - Currently in Shortage)

  • Chlordiazepoxide Hydrochloride Capsules (Updated - Currently in Shortage)

  • Dexamethasone Sodium Phosphate Injection (Updated - Currently in Shortage)

  • Dexmedetomidine Injection (Updated - Currently in Shortage)

  • Epinephrine Injection, Auto-Injector (Updated - Currently in Shortage)

  • Famotidine Tablets (Updated - Currently in Shortage)

  • Guanfacine Hydrochloride Tablets (Updated - Currently in Shortage)

  • Histreline Acetate Implant (New - Discontinuation)

  • Hydromorphone Hydrochloride Injection (Updated - Currently in Shortage)

  • Ketamine Injection (Updated - Currently in Shortage)

  • Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage)

  • Loxapine Capsules (Updated - Currently in Shortage)

  • Nefazodone Hydrochloride Tablets (Updated - Currently in Shortage)

  • Nizatidine Capsules (Updated - Currently in Shortage)

  • Propofol Injectable Emulsion (Updated - Currently in Shortage)

  • Sulfasalazine Tablets (Updated - Currently in Shortage)

  • Vecuronium Bromide for Injection (Updated - Currently in Shortage)

  • Dobutamine Hydrochloride Injection (Updated - Currently in Shortage)

  • Dopamine Hydrochloride Injection (Updated - Currently in Shortage)

  • Heparin Sodium and Sodium Chloride 0.9% Injection (Updated - Currently in Shortage)

  • Mannitol Injection (New - Currently in Shortage)